Distinguished in Age-Related Macular Degeneration (ARMD)

Berthold Seitz

Kirrberger Str. 100, 
Homburg, SL, DE 
Distinguished in Age-Related Macular Degeneration (ARMD)
Kirrberger Str. 100, 
Homburg, SL, DE 
OverviewLocationsClinical Research

Overview

Berthold Seitz practices in Homburg, Germany. Mr. Seitz is rated as a Distinguished expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Keratoconus, Aniridia, Interstitial Keratitis, Corneal Transplant, and Cataract Removal.

His clinical research consists of co-authoring 684 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 28 articles in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

Kirrberger Str. 100, Homburg, SL 66424, Germany
Other Locations
Kirrberger Str. 100/22, Homburg, SL 66424, Germany
100 Kirrberger Str, Homburg, SL 66421, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

German Corneal Cross Linking Register
German Corneal Cross Linking Register
Enrollment Status: Active_not_recruiting
Publish Date: January 10, 2025
Intervention Type: Procedure
A NON-COMMERCIAL, MULTICENTER, RANDOMIZED, TWO-ARMED, OPEN-LABEL PHASE III STUDY TO EVALUATE THE ADJUVANT VACCINATION WITH TUMOR RNA-LOADED AUTOLOGOUS DENDRITIC CELLS VERSUS OBSERVATION OF PATIENTS WITH RESECTED MONOSOMY 3 UVEAL MELANOMA
A NON-COMMERCIAL, MULTICENTER, RANDOMIZED, TWO-ARMED, OPEN-LABEL PHASE III STUDY TO EVALUATE THE ADJUVANT VACCINATION WITH TUMOR RNA-LOADED AUTOLOGOUS DENDRITIC CELLS VERSUS OBSERVATION OF PATIENTS WITH RESECTED MONOSOMY 3 UVEAL MELANOMA
Enrollment Status: Unknown
Publish Date: December 02, 2022
Intervention Type: Biological
Study Drug: Autologous Dendritic Cells Loaded with Autologous Tumor RNA
Study Phase: Phase 3
View 1 Less Clinical Trial

684 Total Publications

Alterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).
Alterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).
Journal: Investigative ophthalmology & visual science
Published: October 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Seitz's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 20 Advanced Conditions
View All 66 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile